SEARCH

SEARCH BY CITATION

References

  • 1
    Fried MW. Management of hepatitis C in the hemophilia patient. Am J Med 1999; 107:85S89S.MEDLINE
  • 2
    Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76:254256.MEDLINE
  • 3
    Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84:10201023.MEDLINE
  • 4
    Kumar A, Kulkarni R, Murray DL, Gera R, Scott-Emuakpor AB, Bosma K, Penner JA. Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia. J Med Virol 1993; 41:205209.MEDLINE
  • 5
    Eyster ME, Sherman KE, Goedert JJ, Katsoulidou A, Hatzakis A. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 1999; 179:10621069.MEDLINE
  • 6
    Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. Br J Haematol 2001; 113:8793.MEDLINE
  • 7
    Tradati F, Colombo M, Mannucci PM, Rumi MG, De Fazio C, Gamba G, Ciavarella N, et al. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91:11731177.MEDLINE
  • 8
    Preston FE, Jarvis LM, Makris M, Philp L, Underwood JC, Ludlam CA, Simmonds P. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 1995; 85:12591262.MEDLINE
  • 9
    Rumi MG, Santagostino E, Morfini M, Gringeri A, Tagariello G, Chistolini A, Pontisso P, et al. A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers. Blood 1997; 89:35293533.MEDLINE
  • 10
    Yoshikawa M, Fukui H, Kojima H, Yoshiji H, Sakamoto T, Imazu H, Nakanani T, et al. Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan. J Gastroenterol 1995; 30:367371.MEDLINE
  • 11
    Bresters D, Mauser-Bunschoten EP, Cuypers HT, Lelie PN, Han JH, Jansen PL, Houghton M, et al. Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients. Scand J Gastroenterol 1992; 27:166168.MEDLINE
  • 12
    Ko JS, Choe YH, Kim EJ, Lee EH, Jang JJ, Seo JK. Interferon-alpha treatment of chronic hepatitis C in children with hemophilia. J Pediatr Gastroenterol Nutr 2001; 32:4144.MEDLINE
  • 13
    Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352:14261432.MEDLINE
  • 14
    McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19(Suppl 1):5765.MEDLINE
  • 15
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:14851492.MEDLINE
  • 16
    Sauleda S, Esteban JI, Altisent C, Puig L, Esteban R, Guardia J. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thromb Haemost 2000; 83:807810.MEDLINE
  • 17
    Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM. Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. Blood 2002; 99:10891091.MEDLINE
  • 18
    Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358:958965.MEDLINE
  • 19
    Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Haussinger D, et al. Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection. N Engl J Med 2002 (in press).
  • 20
    Blanchette VS, Vorstman E, Shore A, Wang E, Petric M, Jett BW, Alter HJ. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 78:285289.MEDLINE
  • 21
    Kanesaki T, Kinoshita S, Tsujino G, Yoshioka K, Ikegami N. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction. J Pediatr 1993; 123:381387.MEDLINE
  • 22
    McHutchison JG, Hoofnagle J. Therapy of chronic hepatitis C. In: TJ L, HoofnagleJ, eds. Hepatitis C. San Diego, CA: Academic, 2000: 203239.
  • 23
    Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994; 20:11211130.MEDLINE
  • 24
    Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16:619624.MEDLINE
  • 25
    Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997; 97:343347.MEDLINE